ATE439865T1 - Extrazelluläre vesikel von nicht-pathogenen amíben verwendbar für den transfer eines moleküles von interesse in eine eukaryotische zelle - Google Patents

Extrazelluläre vesikel von nicht-pathogenen amíben verwendbar für den transfer eines moleküles von interesse in eine eukaryotische zelle

Info

Publication number
ATE439865T1
ATE439865T1 AT04743927T AT04743927T ATE439865T1 AT E439865 T1 ATE439865 T1 AT E439865T1 AT 04743927 T AT04743927 T AT 04743927T AT 04743927 T AT04743927 T AT 04743927T AT E439865 T1 ATE439865 T1 AT E439865T1
Authority
AT
Austria
Prior art keywords
interest
molecule
pathogenic
eukaryotic cell
amíbes
Prior art date
Application number
AT04743927T
Other languages
English (en)
Inventor
Irene Tatischeff
Annette Alfsen
Francoise Lavialle
Original Assignee
Univ Paris Curie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Paris Curie filed Critical Univ Paris Curie
Application granted granted Critical
Publication of ATE439865T1 publication Critical patent/ATE439865T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Inert Electrodes (AREA)
AT04743927T 2003-07-15 2004-07-13 Extrazelluläre vesikel von nicht-pathogenen amíben verwendbar für den transfer eines moleküles von interesse in eine eukaryotische zelle ATE439865T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03291752A EP1498144A1 (de) 2003-07-15 2003-07-15 Extrazelluläre Vesikel von nicht-pathogenen Amöben verwendbar für den Transfer eines Moleküles von Interesse in eine eukaryotische Zelle
PCT/IB2004/002265 WO2005004925A1 (en) 2003-07-15 2004-07-13 Extracellular vesicles from non-pathogenic amoebae useful as vehicle for transferring a molecule of interest to an eukaryotic cell

Publications (1)

Publication Number Publication Date
ATE439865T1 true ATE439865T1 (de) 2009-09-15

Family

ID=33462243

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04743927T ATE439865T1 (de) 2003-07-15 2004-07-13 Extrazelluläre vesikel von nicht-pathogenen amíben verwendbar für den transfer eines moleküles von interesse in eine eukaryotische zelle

Country Status (8)

Country Link
US (2) US7722855B2 (de)
EP (2) EP1498144A1 (de)
AT (1) ATE439865T1 (de)
CA (1) CA2531865C (de)
DE (1) DE602004022676D1 (de)
DK (1) DK1644045T3 (de)
ES (1) ES2331884T3 (de)
WO (1) WO2005004925A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107949B2 (en) * 1996-11-12 2015-08-18 The University Of Akron Method for using naturally occurring gas vesicles as ultrasound contrast agent
US20110053157A1 (en) * 2008-02-01 2011-03-03 The General Hospital Corporation Use of microvesicles in diagnosis, prognosis and treatment of medical diseases and conditions
BR112012001077A2 (pt) * 2009-07-16 2020-08-11 The General Hospital Corporation extração de ácido nucleico, métodos para avaliar a qualidade de uma extração de ácido nucleico e de uma amostra biológica, para ober ácido nucleico a partir de uma amostra biológica, para analisar rna de microvesículas e para diagnosticar e monitorar um indivíduo, e, kit
WO2011027956A2 (ko) 2009-09-04 2011-03-10 주식회사이언메딕스 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델
WO2011027971A2 (ko) 2009-09-01 2011-03-10 주식회사이언메딕스 장내 공생 세균유래 세포밖 소포체, 및 이를 이용한 질병모델, 백신, 후보 약물 탐색 방법, 및 진단 방법
EP3461912B1 (de) 2009-09-09 2022-07-13 The General Hospital Corporation Verwendung von mikrovesikeln bei der analyse von nukleinsäureprofilen
WO2011031892A1 (en) 2009-09-09 2011-03-17 The General Hospital Corporation Use of microvesicles in analyzing kras mutations
US20120315324A1 (en) * 2010-02-05 2012-12-13 University Of Louisville Research Foundation, Inc. Exosomal compositions and methods for the treatment of disease
EP2542696B1 (de) 2010-03-01 2016-09-28 Caris Life Sciences Switzerland Holdings GmbH Theranostik-biomarker
BR112012025593A2 (pt) 2010-04-06 2019-06-25 Caris Life Sciences Luxembourg Holdings biomarcadores em circulação para doença
WO2012031008A2 (en) 2010-08-31 2012-03-08 The General Hospital Corporation Cancer-related biological materials in microvesicles
CA2817111C (en) 2010-11-10 2019-03-05 Exosome Diagnostics, Inc. Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom
KR20180019474A (ko) 2016-08-16 2018-02-26 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
WO2018034457A1 (ko) * 2016-08-16 2018-02-22 주식회사 엠디헬스케어 락토바실러스 속 세균 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
WO2018034430A1 (ko) * 2016-08-16 2018-02-22 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
MX2016014875A (es) * 2016-11-11 2018-05-10 Centro De Investig Y De Estudios Avanzados Del I P N Vesiculas extracelulares gigantes inmunogenicas de protozoos parasitos y metodos para su induccion y purificacion.
GB201702863D0 (en) * 2017-02-22 2017-04-05 Evox Therapeutics Ltd Improved loading of EVs with therapeutic proteins
CN115433684A (zh) * 2022-10-20 2022-12-06 云南师范大学 一种盘基网柄菌细胞同步化方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028215A1 (en) * 1999-08-09 2002-03-07 Jagath L. Kadurugamuwa Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same

Also Published As

Publication number Publication date
US7722855B2 (en) 2010-05-25
US20070104738A1 (en) 2007-05-10
EP1644045A1 (de) 2006-04-12
ES2331884T3 (es) 2010-01-19
US7790196B2 (en) 2010-09-07
EP1498144A1 (de) 2005-01-19
CA2531865C (en) 2012-12-04
EP1644045B1 (de) 2009-08-19
DK1644045T3 (da) 2009-12-14
US20100178702A1 (en) 2010-07-15
DE602004022676D1 (de) 2009-10-01
CA2531865A1 (en) 2005-01-20
WO2005004925A1 (en) 2005-01-20

Similar Documents

Publication Publication Date Title
ATE439865T1 (de) Extrazelluläre vesikel von nicht-pathogenen amíben verwendbar für den transfer eines moleküles von interesse in eine eukaryotische zelle
BR9814404A (pt) " clonagem de expressão em fungos filamentosos "
BRPI0315652B8 (pt) molécula de ácido nucleico isolada, vetor, polipeptídeo de fusão, e, multímero
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
BR0112633A (pt) Método para substituir, translocar e empilhar dna em genomas eucarióticos
EP2302042A3 (de) Polypeptide mit Lipase-Aktivität und diese kodierende Polynukleotide
WO2008140582A3 (en) Production of anti-microbial peptides
DK1131444T3 (da) Polypeptider med lysophospholipase aktivitet og nucleinsyre som koder for disse
DK1100880T3 (da) Urat oxidase
DE60209814D1 (de) Verfahren zur herstellung von ionischen flüssigkeiten
ATE407703T1 (de) Verbindungen und kits zur herstellung von bildgebenden mitteln und bildgebungsverfahren
ATE360071T1 (de) Rezeptor für ein toxin aus bacillus anthracis
NO20072966L (no) Polypeptider som har antimikrobeaktivitet og polynukleotider som koder for disse
DE69937056D1 (de) Verfahren zur transformation von tierzellen
MEP56408A (en) Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
ATE403670T1 (de) Rückgefaltetes membranprotein in monodisperser form
BR0213771A (pt) Molécula de ácido nucleico isolada, vetor, célula hospedeira, e, método para a preparação de um composto de quìmica fina
ATE442445T1 (de) Rhamnose-induzierbares expressionssystem
WO2004108749A3 (en) Binding peptides: methods for their generation and use
WO2007052102A3 (en) Modified green fluorescent proteins and methods for using same
MX2010004699A (es) Plantas que tienen rasgos incrementados relacionados con el rendimiento y un metodo para producirlas.
DE602005017034D1 (de) Signalpeptid zur herstellung eines polypeptids
AU2002346803A1 (en) Genes encoding for carbon metabolism and energy-producing proteins
ATE466874T1 (de) Mit scytovirin der domäne 1 verwandte polypeptide
WO2001085965A3 (en) Vectors for use in transposon-based dna sequencing methods

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties